MedPath

Splenda: Effects on Blood Glucose Concentration, Appetite Scores and Subsequent Energy Intake

Not Applicable
Completed
Conditions
Glucose Metabolism Disorders
Appetitive Behavior
Interventions
Dietary Supplement: Splenda drink
Dietary Supplement: Maltodextrin drink
Dietary Supplement: High carbohydrate breakfast
Registration Number
NCT05810337
Lead Sponsor
King's College London
Brief Summary

This study investigates the effects of Splenda, an artificial sweetener powder containing sucralose, on post-prandial blood glucose levels, appetite scores and subsequent energy intake.

Detailed Description

Participants are randomly assigned to receive either the placebo drink (4.5g maltodextrin dissolved in 250ml water) or the Splenda drink (4.5g Splenda dissolved in 250ml water) taken alongside a high calorie breakfast.

Blood glucose measurements will be obtained through finger-pricking and appetite will be measured using self-reported visual analogue scores rating hunger, desire to eat, fullness and alertness for up to 3 hours after breakfast. Energy intake will be measured using a 24 hour food diary.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
51
Inclusion Criteria
  • Healthy male and female adults (18-64 years)
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Splenda drinkSplenda drinkDrink containing 4.5g Splenda dissolved on 250ml water.
Splenda drinkHigh carbohydrate breakfastDrink containing 4.5g Splenda dissolved on 250ml water.
Maltodextrin drinkMaltodextrin drinkDrink containing 4.5g maltodextrin dissolved on 250ml water.
Maltodextrin drinkHigh carbohydrate breakfastDrink containing 4.5g maltodextrin dissolved on 250ml water.
Primary Outcome Measures
NameTimeMethod
Change in blood glucose-5 to 180 minutes (measured from baseline up to 90min every 15min and from 90-180min every 30min)

Capillary blood glucose from fingerprick and measured using glucose monitor

Change in appetite-5 to 180 minutes (measured from baseline up to 90min every 15min and from 90-180min every 30min)

Feelings of hunger, desire to eat, fullness and alertness measured using Visual Analogue Scale (VAS)

Secondary Outcome Measures
NameTimeMethod
24 hour energy intake0 - 24 hours

Food intake over the 24 hours of the study day using a 24 hour food diary entered into dietary analysis software

Trial Locations

Locations (1)

King's College London

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath